16S rRNA基因宏基因组测序检测脓毒症患者病原菌
本研究前瞻性收集60例脓毒症患者血浆,比较常规血培养与基于血浆游离DNA的16S rRNA基因PCR/NGS对病原菌的检测与鉴定效果。19例(32%)血培养阳性,16S rRNA基因NGS concordant 11例, discordant 5例,阴性3例;在41例血培养阴性者中NGS检出至少1种潜在病原菌17例,其中15例与临床综合征相关。结论认为16S rRNA基因NGS可能有助于检测脓毒症患者血浆中的细菌,并可能根据血浆菌群特征推断革兰阴性脓毒症的胃肠道或泌尿道来源。
要点
- 16S rRNA基因NGS与血培养在部分脓毒症患者中结果一致,但存在不一致检测。
- 血培养阴性脓毒症患者中NGS可检出潜在病原菌,部分与临床综合征相关。
- 革兰阴性菌脓毒症中,NGS检测的菌群特征可能提示胃肠道或泌尿道来源。
核心结论
- 16S rRNA基因NGS可能有助于检测脓毒症患者血浆中的细菌,并可能根据血浆菌群特征推断革兰阴性脓毒症的胃肠道或泌尿道来源。
研究设计与样本
- 前瞻性收集2019年3月至8月Mayo Clinic(明尼苏达州)急诊科60例成人脓毒症患者的血浆,比较常规临床血培养与16S rRNA基因PCR/NGS的结果。
主要发现
- 19例(32%)受试者血培养阳性,其中13例为革兰阴性杆菌,5例为革兰阳性球菌,1例同时检出革兰阴性杆菌和革兰阳性球菌。
- 16S rRNA基因NGS与血培养结果一致11例,其余8例中不一致检测5例、NGS阴性3例。
- 在6例胃肠道来源革兰阴性菌血症中,3例经16S rRNA基因NGS额外检出梭菌属;3例泌尿道来源革兰阴性菌血症中无此发现。
- 41例血培养阴性受试者中,16S rRNA基因NGS检出至少1种潜在病原菌17例,其中15例检测微生物与患者临床综合征相关。
- 17例有临床定义感染综合征的受试者两项检测均阴性;其余7例确定了非感染性病因。
临床怎么用
- 对于脓毒症患者,16S rRNA基因NGS可作为血培养的补充检测,尤其在血培养阴性但临床高度怀疑感染时。
- 在革兰阴性菌脓毒症中,可根据血浆NGS检出的菌群特征辅助推断胃肠道或泌尿道来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional blood cultures were compared to plasma cell-free DNA-based 16S ribosomal RNA (rRNA) gene polymerase chain reaction (PCR)/next-generation sequencing (NGS) for detection and identification of potential pathogens in patients with sepsis. METHODS: Plasma was prospectively collected from 60 adult patients with sepsis presenting to the Mayo Clinic (Minnesota) Emergency Department from March through August 2019. Results of routine clinical blood cultures were compared to those of 16S rRNA gene NGS. RESULTS: Nineteen (32%) subjects had positive blood cultures, of which 13 yielded gram-negative bacilli, 5 gram-positive cocci, and 1 both gram-negative bacilli and gram-positive cocci. 16S rRNA gene NGS findings were concordant in 11. For the remaining 8, 16S rRNA gene NGS results yielded discordant detections (n = 5) or were negative (n = 3). Interestingly, Clostridium species were additionally detected by 16S rRNA gene NGS in 3 of the 6 subjects with gastrointestinal sources of gram-negative bacteremia and none of the 3 subjects with urinary sources of gram-negative bacteremia. In the 41 remaining subjects, 16S rRNA gene NGS detected at least 1 potentially pathogenic organism in 17. In 15, the detected microorganism clinically correlated with the patient's syndrome. In 17 subjects with a clinically defined infectious syndrome, neither test was positive; in the remaining 7 subjects, a noninfectious cause of clinical presentation was identified. CONCLUSIONS: 16S rRNA gene NGS may be useful for detecting bacteria in plasma of septic patients. In some cases of gram-negative sepsis, it may be possible to pinpoint a gastrointestinal or urinary source of sepsis based on the profile of bacteria detected in plasma.
引用
- Fida M, Wolf MJ, Hamdi A, et al. Detection of Pathogenic Bacteria From Septic Patients Using 16S Ribosomal RNA Gene-Targeted Metagenomic Sequencing. Clin Infect Dis. 2021. PMID: 33893492. doi:10.1093/cid/ciab349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。